The U.S. Food and Drug Administration (FDA) has approved ciclopirox (Penlac Nail Lacquer) topical solution, 8 percent, for the treatment of onychomycosis. Ciclopirox is the first topical treatment for nail fungus approved by the FDA.
Ciclopirox penetrates the nail to specifically target the infected area. The most common side effect of ciclopirox is mild redness around the nail bed.
According to the manufacturer, the topical solution may be safer than systemic treatments in some patients who are at risk for possibly dangerous drug interactions. For more information on ciclopirox, visit the FDA Web site at http://www.fda.gov.
COPYRIGHT 2001 American Academy of Family Physicians
COPYRIGHT 2001 Gale Group
Home
A
Cabergoline
